CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

Chapter 8 - Diseases of the ear and mastoid process (H60-H95)»Other disorders of ear (H90-H94)»Conductive and sensorineural hearing loss (H90)

H90

Conductive and sensorineural hearing loss

Sub-codes (10)

  • H90.0 Conductive hearing loss, bilateral
  • H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
  • H90.2 Conductive hearing loss, unspecified

    1 indication for 1 drug

  • H90.3 Sensorineural hearing loss, bilateral
  • H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
  • H90.5 Unspecified sensorineural hearing loss

    2 indications for 49 drugs

  • H90.6 Mixed conductive and sensorineural hearing loss, bilateral
  • H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
  • H90.8 Mixed conductive and sensorineural hearing loss, unspecified
  • H90.A Conductive and sensorineural hearing loss with restricted hearing on the contralateral side

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.